NCT06974110 2026-04-15
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
MOMA Therapeutics
Merck Sharp & Dohme LLC
Artios Pharma Ltd
City of Hope Medical Center
Jiangsu Hansoh Pharmaceutical Co., Ltd.